{"id":64854,"date":"2024-11-02T12:22:58","date_gmt":"2024-11-02T12:22:58","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=64854"},"modified":"2026-04-30T10:15:58","modified_gmt":"2026-04-30T10:15:58","slug":"raloxiheal","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nl\/raloxiheal\/","title":{"rendered":"Raloxiheal"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:18px 0;border-radius:4px;\">\n<p style=\"margin:0 0 8px 0;\"><strong>\ud83d\udca1 Snel antwoord<\/strong><\/p>\n<p style=\"margin:0;\"><strong>Raloxiheal<\/strong> is <strong>raloxifene 60 mg<\/strong>, a selective estrogen receptor modulator (SERM) with dual approval: <strong>prevention and treatment of postmenopausal osteoporosis<\/strong>, en <strong>reduction of invasive breast cancer risk<\/strong> in high-risk postmenopausal women. Unlike estrogen, raloxifene is NOT an HRT for hot flushes \u2014 it can worsen them. Safer breast-cancer profile than estrogen, but comparable VTE risk.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Wat u krijgt bij MedsBase:<\/strong> WHO-GMP gecertificeerde fabrikant \u00b7 Discrete verpakking \u00b7 Wereldwijde verzending \u00b7 1.400+ geverifieerde <a href=\"https:\/\/medsbase.com\/nl\/reviews\/\">klantbeoordelingen<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Elke bestelling is gedekt door onze <a href=\"https:\/\/medsbase.com\/nl\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n<div style=\"background:#f4f8fb;border-left:4px solid #2c7cb0;padding:14px 20px;margin:16px 0;border-radius:4px;font-size:0.95em;\">\n<strong>\ud83d\udd12 Wat u krijgt bij MedsBase:<\/strong> WHO-GMP gecertificeerde fabrikant \u00b7 Discrete eenvoudige verpakking (geen medicatienaam aan de buitenkant) \u00b7 Wereldwijde verzending \u00b7 Lees onze <a href=\"https:\/\/medsbase.com\/nl\/reviews\/\">1.400+ klantbeoordelingen<\/a>\n<\/div>\n<h3>Waarom bestellen bij MedsBase<\/h3>\n<p>Elke MedsBase-bestelling wordt verzonden door een WHO-GMP gecertificeerde fabrikant in eenvoudige, volledig discrete verpakking \u2014 aan de buitenkant is niets te zien dat de inhoud of de apotheek identificeert. Betalingen met kaart verlopen via een gereguleerde crypto-onramp; de omschrijving op uw bankafschrift is de naam van de verwerker (een gereguleerde kaartbetalingverwerker) \u2014 nooit \u201cMedsBase\u201d of iets apotheekgerelateerds. Cryptobetalingen via Plisio blijven volledig anoniem. Elk pakket valt onder onze <a href=\"https:\/\/medsbase.com\/nl\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>.<\/p>\n<h2><strong>What Is Raloxiheal?<\/strong><\/h2>\n<p>Raloxiheal is a branded generic of <strong>raloxifene 60 mg<\/strong>, een <strong>selective estrogen receptor modulator (SERM)<\/strong>. SERMs have estrogen-like effects in some tissues and anti-estrogen effects in others. Raloxifene mimics estrogen in bone (positive \u2014 builds density) but blocks estrogen in breast tissue (positive \u2014 reduces breast cancer risk). It has neutral or mild effects on the uterus (unlike tamoxifen, which carries endometrial cancer risk). Manufactured by Healing Pharma.<\/p>\n<h2><strong>FDA-Approved Indications<\/strong><\/h2>\n<ul>\n<li><strong>Preventie van postmenopauzale osteoporose<\/strong> \u2014 typically in women 5+ years past menopause with moderate bone-density loss.<\/li>\n<li><strong>Treatment of postmenopausal osteoporosis<\/strong> \u2014 reduces vertebral fracture risk by ~40\u201350% over 3 years.<\/li>\n<li><strong>Reduction of invasive breast cancer risk<\/strong> in postmenopausal women at high risk. The STAR trial showed raloxifene 60 mg reduced invasive breast cancer risk ~50% (similar to tamoxifen) with fewer thromboembolic events and less endometrial cancer risk.<\/li>\n<\/ul>\n<h2><strong>When Raloxifene Is Right For You<\/strong><\/h2>\n<ul>\n<li><strong>You have<\/strong>: osteoporosis OR high breast cancer risk, age \u226560 or at least 5 years post-menopause<\/li>\n<li><strong>You do not have<\/strong>: active hot flushes (raloxifene worsens them), VTE history, active liver disease, pregnancy potential<\/li>\n<li><strong>Alternatives:<\/strong> bisphosphonates (alendronate, risedronate), denosumab, teriparatide for osteoporosis; tamoxifen as alternative SERM for breast cancer prevention (premenopausal option)<\/li>\n<\/ul>\n<h2><strong>Hoe in te nemen<\/strong><\/h2>\n<ol>\n<li>Neem <strong>one 60 mg tablet once daily<\/strong>, at any time, with or without food.<\/li>\n<li>Take with adequate calcium (1000\u20131200 mg\/day) and vitamin D (800\u20131000 IU\/day) \u2014 raloxifene works better with sufficient bone substrate.<\/li>\n<li>Effects on bone density appear at 6\u201312 months; fracture risk reduction is continuous with ongoing use.<\/li>\n<li>Breast cancer risk reduction begins within months; maintained over years of use.<\/li>\n<li>Typical duration: <strong>5 jaar<\/strong> for bone indications; <strong>up to 5 years<\/strong> for breast cancer risk reduction.<\/li>\n<\/ol>\n<h2><strong>Bijwerkingen<\/strong><\/h2>\n<p><strong>Vaak voorkomend:<\/strong> hot flushes (new onset or worsening \u2014 up to 25%), leg cramps, peripheral oedema, flu-like symptoms, joint pain, sweating.<\/p>\n<p><strong>Minder vaak:<\/strong> breast tenderness, depression, rash.<\/p>\n<p><strong>Ernstig (zeldzaam):<\/strong> VTE (DVT, PE) \u2014 risk similar to estrogen; fatal stroke in postmenopausal women with coronary heart disease (RUTH trial); retinal vein thrombosis.<\/p>\n<h2><strong>Who Should Not Take Raloxiheal<\/strong><\/h2>\n<ul>\n<li><strong>Active or history of VTE (DVT, PE)<\/strong> \u2014 raloxifene raises risk 2\u20133\u00d7<\/li>\n<li>Women with history of stroke (RUTH trial showed increased stroke fatality in women with coronary heart disease)<\/li>\n<li>Pregnancy or women who might become pregnant<\/li>\n<li>Children and adolescents<\/li>\n<li>Actieve leverziekte<\/li>\n<li>Ernstige nierfunctiestoornis<\/li>\n<li>Undiagnosed vaginal bleeding (investigate first)<\/li>\n<li>Active breast or endometrial cancer (discuss individually)<\/li>\n<\/ul>\n<h2><strong>Raloxifene vs Alternatives \u2014 Decision Table<\/strong><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:12px 0;\">\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Goal<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Eerstelijns<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Raloxifene&#8217;s role<\/th>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vasomotor (hot flush) relief<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Estrogen \/ tibolone<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Not indicated \u2014 worsens hot flushes<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Postmenopauzale osteoporose<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Alendronate \/ other bisphosphonates<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Good alternative; strongest evidence for vertebral fracture<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Risicovermindering voor borstkanker<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Tamoxifen (premenopausal) or raloxifene (postmenopausal)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Better side-effect profile than tamoxifen for postmenopausal use<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Combined bone + breast cancer goals<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Raloxifene<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Single drug covers both<\/td>\n<\/tr>\n<\/table>\n<h2><strong>Opslag<\/strong><\/h2>\n<p>Store at room temperature (15\u201325 \u00b0C). Keep in original blister, away from moisture and light. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">Veelgestelde vragen<\/h2>\n<h3 class=\"wp-block-heading\">Is raloxifene the same as estrogen?<\/h3>\n<p>No \u2014 it is a selective estrogen receptor modulator (SERM). It acts like estrogen in bone (positive) but blocks estrogen in breast tissue (also positive, for cancer risk reduction). Uterine effect is neutral. Unlike estrogen, it does NOT treat hot flushes \u2014 it often worsens them.<\/p>\n<h3 class=\"wp-block-heading\">Will raloxifene cause hot flushes?<\/h3>\n<p>Yes, in ~25% of users \u2014 either new-onset or worsening of existing flushes. This is the classic raloxifene trade-off: you get bone and breast protection but not symptom relief.<\/p>\n<h3 class=\"wp-block-heading\">Can I combine raloxifene with estrogen?<\/h3>\n<p>No \u2014 combination negates the benefits. If you need hot flush relief AND bone protection, discuss options with a clinician: short-term estrogen first, then switch to raloxifene or bisphosphonate.<\/p>\n<h3 class=\"wp-block-heading\">How long do I need to take Raloxiheal?<\/h3>\n<p>Typical courses are 3\u20135 years for osteoporosis; 5 years for breast cancer prevention. Longer duration is fine for ongoing osteoporosis protection.<\/p>\n<h3 class=\"wp-block-heading\">What about calcium and vitamin D?<\/h3>\n<p>Yes \u2014 raloxifene works best combined with adequate calcium (1000\u20131200 mg\/day) and vitamin D (800\u20131000 IU\/day). These provide the substrate raloxifene helps retain.<\/p>\n<h3 class=\"wp-block-heading\">Does raloxifene reduce hip fracture risk?<\/h3>\n<p>Trial data (MORE, CORE) show strong vertebral fracture reduction (~40\u201350%) but less conclusive effect on hip fracture. For hip-fracture-focused protection, bisphosphonates or denosumab may be preferred.<\/p>\n<h3 class=\"wp-block-heading\">What is the VTE risk?<\/h3>\n<p>Raloxifene raises VTE risk ~2\u20133\u00d7 (similar to estrogen). Risk is highest in the first 4 months. Stop raloxifene 3 days before prolonged immobilisation, surgery, or long flights; resume when mobile.<\/p>\n<h3 class=\"wp-block-heading\">Is raloxifene safer than tamoxifen for breast cancer prevention?<\/h3>\n<p>For postmenopausal women, yes \u2014 raloxifene has lower endometrial cancer risk and fewer thromboembolic events vs tamoxifen, with similar invasive breast cancer risk reduction (STAR trial).<\/p>\n<h3 class=\"wp-block-heading\">Gerelateerde Hormoon- &amp; Vrouwengezondheidsproducten<\/h3>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/nl\/premarin\/\">Premarin (Geconjugeerde Oestrogenen)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nl\/premarin-cream\/\">Premarin Cr\u00e8me (Vaginaal Oestrogeen)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nl\/progynova\/\">Progynova (Estradiolvaleraat)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nl\/endogest\/\">Endogest (Progesteron 100 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nl\/gestoford\/\">Gestoford (Progesteron 100 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nl\/gestheal\/\">Gestheal (Progesteron 200 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nl\/susten-capsule\/\">Susten Capsule (Progesteron)<\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 20px;margin:16px 0;border-radius:4px;font-size:0.9em;\">\n<p style=\"margin:0;\"><strong>\u2695\ufe0f Medische disclaimer:<\/strong> De informatie is educatief en vervangt geen medisch advies. Hormoontherapie\u00ebn brengen specifieke risico's met zich mee (borstkanker, VTE, beroerte, baarmoederkanker bij ongeopponeerde oestrogeen) \u2014 raadpleeg een arts voordat u begint, stopt of verandert met hormoonmedicatie. Het individuele risico\u2013voordeel hangt af van persoonlijke en familiale medische geschiedenis.<\/p>\n<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Gerelateerde alternatieven<\/h3>\n<p>Andere producten in <strong>Chronische aandoeningen<\/strong> die klanten ook bekijken:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/nl\/foracort-inhaler\/\">Foracort Inhaler<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nl\/hytrin\/\">Hytrin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nl\/dilzem-cd\/\">Dilzem CD<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nl\/calpol\/\">Calpol<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/nl\/betnesol-tab\/\">Betnesol Tab<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Ondersteunt de botgezondheid<br \/>\n\u2705 Vermindert het risico op fracturen<br \/>\n\u2705 Verlaagt cholesterolgehalte<br \/>\n\u2705 Voorkomt osteoporose<br \/>\n\u2705 Menopause symptom relief<\/p>\n<p>Raloxiheal contains <strong>Raloxifene<\/strong>.<\/p>","protected":false},"featured_media":64855,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3223,3519,3502],"product_tag":[5324,5323],"class_list":{"0":"post-64854","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-chronic-conditions","7":"product_cat-hormone-replacement-therapy-hrt-medication-for-menopause","8":"product_cat-womens-health","9":"product_tag-raloxifene","10":"product_tag-raloxiheal","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product\/64854","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/comments?post=64854"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media\/64855"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media?parent=64854"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_brand?post=64854"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_cat?post=64854"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_tag?post=64854"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}